Press Releases
August 23, 2018 - ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team
December 12, 2016 - Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy
In the News
December 12, 2016 - ApoGen Biotechnologies Raises $7 Million Series A: Startup secures capital to defeat genetic mechanisms that help tumors resist treatments (wsj.com)
December 12, 2016 - ApoGen Biotech Lands $7M to Take On Drug Resistance in Cancer (Xconomy.com)
December 12, 2016 - ApoGen secures $7M Series A with Accelerator Corporation (MedCityNews.com)
December 12, 2016 - ApoGen rakes in $7 mln Series A (pehub.com)
December 12, 2016 - ApoGen debuts with $7M (BioCentury.com)